- Home
- TEM vs PCVX Comparison
TEM vs PCVX Comparison
Compare TEM & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TEM
- PCVX
- Stock Information
- Founded
- TEM 2015
- PCVX 2013
- Country
- TEM United States
- PCVX United States
- Employees
- TEM N/A
- PCVX N/A
- Industry
- TEM
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- TEM
- PCVX Health Care
- Exchange
- TEM NYSE
- PCVX Nasdaq
- Market Cap
- TEM 9.3B
- PCVX 12.5B
- IPO Year
- TEM 2024
- PCVX 2020
- Fundamental
- Price
- TEM $47.49
- PCVX $114.48
- Analyst Decision
- TEM Strong Buy
- PCVX Strong Buy
- Analyst Count
- TEM 9
- PCVX 7
- Target Price
- TEM $45.25
- PCVX $147.50
- AVG Volume (30 Days)
- TEM 1.3M
- PCVX 1.4M
- Earning Date
- TEM 08-06-2024
- PCVX 11-04-2024
- Dividend Yield
- TEM N/A
- PCVX N/A
- EPS Growth
- TEM N/A
- PCVX N/A
- EPS
- TEM N/A
- PCVX N/A
- Revenue
- TEM $595,570,000.00
- PCVX N/A
- Revenue This Year
- TEM $32.58
- PCVX N/A
- Revenue Next Year
- TEM $32.44
- PCVX N/A
- P/E Ratio
- TEM N/A
- PCVX N/A
- Revenue Growth
- TEM 85.73
- PCVX N/A
- 52 Week Low
- TEM $22.89
- PCVX $44.20
- 52 Week High
- TEM $77.00
- PCVX $119.50
- Technical
- Relative Strength Index (RSI)
- TEM N/A
- PCVX 80.13
- Support Level
- TEM N/A
- PCVX $112.55
- Resistance Level
- TEM N/A
- PCVX $119.50
- Average True Range (ATR)
- TEM 0.00
- PCVX 4.20
- MACD
- TEM 0.00
- PCVX 2.38
- Stochastic Oscillator
- TEM 0.00
- PCVX 88.12
About TEM TEMPUS AI INC
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.